News from transition therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 12, 2015, 16:01 ET

Transition Therapeutics Announces Third Quarter Fiscal 2015 Financial Results

TORONTO, May 12, 2015 /PRNewswire/ -Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...

May 07, 2015, 16:01 ET

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2015 Financial Results on Tuesday, May 12th, at 4:30 P.M. EST

TORONTO, May 7, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...

May 06, 2015, 06:01 ET

Transition Therapeutics In-Licenses Phase 2 Drug Candidate from Lilly

TORONTO, May 6, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced its...

Mar 26, 2015, 06:01 ET

Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005

TORONTO, March 26, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced...

Mar 02, 2015, 06:02 ET

Transition Therapeutics Announces Enrolment Completion of ELND005 Phase 2 Clinical Study in Agitation and Aggression in Patients with Alzheimer's Disease

TORONTO, March 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that its...

Feb 19, 2015, 13:30 ET

Transition Therapeutics to Present at the Cowen and Company 35th Annual Healthcare Conference

TORONTO, Feb. 19, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...

Feb 18, 2015, 16:01 ET

Transition Therapeutics Inc. Announces Closing of Public Offering of US$23 Million of Common Shares

TORONTO, Feb. 18, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced...

Feb 12, 2015, 08:00 ET

Transition Therapeutics Inc. Announces Pricing of Public Offering of US$20 Million of Common Shares

TORONTO, Feb. 12, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH)...

Feb 11, 2015, 16:01 ET

Transition Therapeutics Inc. Announces Public Offering of Common Shares

TORONTO, Feb. 11, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that it...

Feb 09, 2015, 16:01 ET

Transition Therapeutics Announces Second Quarter Fiscal 2015 Financial Results

TORONTO, Feb. 9, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...

Feb 05, 2015, 12:00 ET

Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2015 Financial Results on Monday, February 9th, at 4:30 P.M. EST

TORONTO, Feb. 5, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Dec 08, 2014, 16:35 ET

Transition Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference

TORONTO, Dec. 8, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that Dr....

Nov 24, 2014, 06:01 ET

Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval

TORONTO, Nov. 24, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced results...

Nov 20, 2014, 06:01 ET

Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome

TORONTO, Nov. 20, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...

Nov 12, 2014, 16:01 ET

Transition Therapeutics Announces First Quarter Fiscal 2015 Financial Results

TORONTO, Nov. 12, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...

Nov 10, 2014, 06:01 ET

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2015 Financial Results on Wednesday, November 12th, at 4:30 P.M. EST

TORONTO, Nov. 10, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...

Nov 04, 2014, 06:01 ET

Transition Therapeutics Reports Findings from Bipolar Disorder Phase 2 Study

TORONTO, Nov. 4, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced findings...

Sep 25, 2014, 16:01 ET

Transition Therapeutics Announces Fiscal 2014 Year End Financial Results

TORONTO, Sept. 25, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...

Sep 22, 2014, 06:01 ET

Transition Therapeutics to Hold Conference Call on Full Year Fiscal 2014 Financial Results on Thursday, September 25th, at 4:30 P.M. EST

TORONTO, Sept. 22, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...

Sep 05, 2014, 06:01 ET

Transition Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference

TORONTO, Sept. 5, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...